Dataset opportunity
Elevationspine — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Elevationspine, usable for Diagnostic AI and Computer Vision.
Score
47.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Medical Diagnostics Market = $1.1 Billion in 2023, CAGR 25.2%.
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-08-11
Elevation Spine lands FDA clearance for expandable interbody fusion system
medicaldevice-network.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Elevationspine holds a specialized Medical Imaging Dataset derived from its work in the spinal healthcare sector. The dataset uniquely combines proprietary preclinical biomechanical data (`industrial_data`) with real-world evidence from clinical registries (`medical_records`), offering a comprehensive view of spinal conditions suitable for training and validating Diagnostic AI algorithms.
This data is positioned in the rapidly growing AI in Medical Diagnostics market, which was valued at $1.1 Billion in 2023 and is projected to expand at a CAGR of 25.2%. [7] Despite access complexities requiring HIPAA/GDPR compliance for patient information and specific IP licensing for its proprietary biomechanical data, the rarity and regulatory-grade nature of this evidence make it a highly valuable asset for developing next-generation diagnostic tools in a market with intense demand. ⚠ Diligence (valuable data, access to negotiate): Clinical registry data contains Protected Health Information (PHI) requiring HIPAA/GDPR compliance.; Preclinical biomechanical data is proprietary and 'on file', requiring specific IP licensing.; Access to real-world evidence (RWE) depends on surgeon-partner agreements. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Elevation Spine possesses a proprietary clinical registry of medical images from an estimated 200 patients, directly linked to its FDA-cleared Saber-C cervical fusion device. This high-rarity, real-world dataset is a prime asset for medical AI firms looking to train or validate diagnostic AI for spinal imaging. In a global AI diagnostics market projected to grow at over 25% annually, access to such clinically-relevant orthopedic data offers a distinct competitive advantage.
See dimension details ↓- Dataset Specificity90
dominant 'medical_records', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
Buyer demand is exceptionally high, driven by the AI in Medical Diagnostics market's rapid expansion at a 25.2% CAGR, which creates an urgent need for specialized, high-quality imaging data. [7]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
ownership=mixed, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation73
3 data-appetite signals (3 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 1 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit58
⚠ review — The company's core business is developing and selling medical devices (spinal implants), not providing a service that generates data as a byproduct, making it a poor fit. Issues: The company's core product is a physical medical device (spinal fusion implants), which it sells. [1, 2, 7]; The company does not have a real operational business that generates data as a by-product in the sense of the ICP (e.g., a fleet, inspections, a marketplace). I; The reference to 'data points' from implantations refers to surgeon feedback for product improvement, not a proprietary, structured dataset generated from opera
- Deep Qualification80
✓ pass — Elevationspine is a medical device manufacturer, making it a `tooling_vendor`. The clinical and imaging data is generated and owned by its customers (surgeons/hospitals), not by the company itself. While the company does possess proprietary preclinical data and is establishing a clinical registry, the rights to access and resell the valuable real-world imaging data are not inherent and depend on specific, unverified agreements with healthcare providers.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Medical records / imaging
The company is building a clinical registry with an estimated 200 patients, providing a structured collection of real-world medical images highly valuable for training diagnostic AI on post-operative outcomes.
Industrial data
The company holds unpublished preclinical data on file, offering deep technical context on the device's material performance and biological interactions that can enrich the interpretation of the associated images.
Regulatory records
Official filings confirm FDA clearance for the company's devices, which validates the clinical process and ensures the associated patient data is generated under rigorous regulatory standards.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Coverage
Scanned sources
Deliverable
Premium dataset report
Elevationspine Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Diagnostics Market = $1.1 Billion in 2023, CAGR 25.2% (source: Market.us). [7]. Investment score 47.5/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Crs Medical — Maintenance Logs Dataset Opportunity
View opportunity →healthcareHospital Engineering — Maintenance Logs Dataset Opportunity
View opportunity →healthcareJacobsbiomedical — Maintenance Logs Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- What is a Dataset Worth?3 min read
- How a Data Transaction Works3 min read
- What you are entitled to sell3 min read